Education
About Us
Working with TipRanks
Follow Us
N4 Pharma PLC (GB:N4P)
LSE:N4P
N4P Stock Chart & Stats
Day’s Range― - ―
52-Week Range0.37p - 0.92p
Previous CloseN/A
Volume555.10K
Average Volume (3M)2.33M
Market Cap
£5.70M
Enterprise Value37.15K
Total Cash (Recent Filing)£793.14K
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)―
Beta0.50
Next Earnings
Sep 17, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding394,780,330
10 Day Avg. Volume1,238,850
30 Day Avg. Volume2,325,201
Standard Deviation0.27
R-Squared0.03
Alpha0.00968
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)353.75
Price to Cash Flow (P/CF)-2.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
N4 Pharma News
PremiumCompany Announcements
N4 Pharma PLC Announces Change in Major Shareholdings
PremiumCompany Announcements
N4 Pharma Schedules Investor Presentation on RNA Therapeutic Development
PremiumCompany Announcements
N4 Pharma Strengthens Board with Strategic Appointment of Dr. Alastair Smith
PremiumCompany Announcements
N4 Pharma’s New Patent Targets IBD TreatmentPremiumCompany Announcements
N4 Pharma Grants 15 Million Options to Key Directors
PremiumCompany Announcements
N4 Pharma Engages Investors with CEO Q&A SessionPremiumCompany Announcements
N4 Pharma Showcases Strategic Focus and Growth Plans---
N4P FAQ
What was N4 Pharma PLC’s price range in the past 12 months?
N4 Pharma PLC lowest share price was 0.36p and its highest was 0.92p in the past 12 months.
What is N4 Pharma PLC’s market cap?
N4 Pharma PLC’s market cap is £5.70M.
When is N4 Pharma PLC’s upcoming earnings report date?
N4 Pharma PLC’s upcoming earnings report date is Sep 17, 2025 which is in 198 days.
How were N4 Pharma PLC’s earnings last quarter?
Currently, no data Available
Is N4 Pharma PLC overvalued?
According to Wall Street analysts N4 Pharma PLC’s price is currently Overvalued.
Does N4 Pharma PLC pay dividends?
N4 Pharma PLC does not currently pay dividends.
What is N4 Pharma PLC’s EPS estimate?
N4 Pharma PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does N4 Pharma PLC have?
N4 Pharma PLC has 394,780,330 shares outstanding.
What happened to N4 Pharma PLC’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of N4 Pharma PLC?
Currently, no hedge funds are holding shares in GB:N4P
---
Company Description
N4 Pharma PLC
N4 Pharma PLC is a United Kingdom-based specialist pharmaceutical company. The company is engaged in reformulating existing drugs and vaccines to improve their performance to benefit the patients. The group operates in one business segment, that of the development and commercialization of medicines via its delivery system called Nuvec.
---
Technical Analysis
---